Adoptive Cellular Therapy at a Glance

Adoptive cellular therapy (ACT), which includes tumor-infiltrating lymphocyte (TIL) therapy; T-cell receptor (TCR) therapy; and Chimeric Antigen Receptor (CAR) T-cell therapy, is at a critical juncture. While some successes have been realized, broader life-saving successes have often been stymied by research and technology shortcomings. Fortunately, recent genomic, immunologic, and cell manufacturing advances have shown promise in overcoming the obstacles that have impeded greater ACT progress. Download this infographic now to learn more about how ACTs work, what’s in the pipeline, and some of the success stories having a big impact on cancer patients.

Download Now

    Please fill out the information below to download the content. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.